Data as of Nov 26
| +0.64 / +1.48%|
The 13 analysts offering 12-month price forecasts for Imperva Inc have a median target of 42.00, with a high estimate of 52.00 and a low estimate of 34.00. The median estimate represents a -4.18% decrease from the last price of 43.83.
The current consensus among 15 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.